Reduced-intensity conditioning prior to allogeneic transplantation of hematopoietic stem cells: the need for T cells early after transplantation to induce a graft-versus-lymphoma effect
- 26 July 2004
- journal article
- research article
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 34 (5), 391-397
- https://doi.org/10.1038/sj.bmt.1704600
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow TransplantationBlood, 2002
- Role of Nonmyeloablative Allogeneic Stem-Cell Transplantation After Failure of Autologous Transplantation in Patients With Lymphoproliferative MalignanciesJournal of Clinical Oncology, 2002
- Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trialThe Lancet, 2002
- Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison ofhigh-dose conventional conditioning versusfludarabine-based reduced-intensity regimensAnnals of Oncology, 2002
- Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphomaAnnals of Hematology, 2002
- Allogeneic stem-cell transplantation for lymphoproliferative disorders using BEAM–CAMPATH (± fludarabine) conditioning combined with post-transplant donor-lymphocyte infusionCytotherapy, 2001
- Reduced-intensity allogeneic stem cell transplantation as salvage treatment for patients with indolent lymphoma or CLL after failure of autologous SCTBone Marrow Transplantation, 2000
- BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factorsBone Marrow Transplantation, 1997
- Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's LymphomaThe New England Journal of Medicine, 1995
- Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and high-grade non-Hodgkin's lymphoma with cyclophosphamide, carmustine, and etoposide.Journal of Clinical Oncology, 1993